Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy.
Dong-Mei ZhuJing XieChun-Yan YeMei-Yun QianYuan XuePublished in: Canadian journal of gastroenterology & hepatology (2020)
The risk of HCC remains to be high in patients with HBV-related DC, especially in males aged ≥50 years.